Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 23, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Epigenetic AgingImmunosenescence

Interventions

COMBINATION_PRODUCT

TRIIM Treatment

Personalized combination of somatropin, metformin, and DHEA

COMBINATION_PRODUCT

Active Control

Metformin and DHEA

Trial Locations (1)

RECRUITING

Intervene Immune, Torrance

All Listed Sponsors

lead

Intervene Immune, Inc.

INDUSTRY